维普中文期刊产品整合服务
60篇 您的检索式:期刊名="Drug Design Development Therapy"
    题名 作者 年代 出处 被引量
1Efficacy and sat)ty of febuxostat inthe treatment of hyperuricemia in stable kidney transplant recipients显示文摘Sofue T hmi M Hara T 2014Drug design development and therapy2014,17,8:1
2Management of advanced breast cancer with the epothilone B analog, ixabepilone 显示文摘Gradishar W 2009Drug Design Development and Therapy2009,3,:1
3The efficacy of ampicillin and Lactobacillus casei rhamnosusin the active manage- ment of preterm premature rupture of membranes remote from term 显示文摘Salih Burcin Kayak Ebru Kavak Rasit llhan 2014Drug Design Development and Therapy2014,8,:1
4Adding thiazide to a rennin-angiotensin blocker regimen to improve left ventricular relaxation in diabetes and nondiabetes patients with hypertension显示文摘Takeshi Takami Yoshikawa Watanabe Iwakura Shimada Ishii Ito Fukuda 2012Drug Design, Development and Therapy . 2012 (defa)2012,,:1
5Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment显示文摘Stuart Ibsen Esener Schutt 2013Drug Design, Development and Therapy . 2013 (defa)2013,,:1
6Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma:a review of the evidence to date显示文摘Tuttolomondo A Pecoraro R Pinto A 2014Drug Design Development Therapy2014,8,:1
7Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis显示文摘Giovanni Pitari 2013Drug Design, Development and Therapy . 2013 (defa)2013,,:1
8Review of pramlinfide as adjunctive therapy in treatment of typel and type2 diabetes显示文摘Ryan G Briscoe TA Jobe L 2008Drug Design Development and Therapy2008,2,1:1
9Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases显示文摘Thomas Polascik 2008Drug Design, Development and Therapy . 2008 (defa)2008,,:1
10Effect of aliskiren on cardiovascular out-comes in patients with prehypertension:a meta-analysis of randomized con-trolled trials显示文摘ZhangJ T Chen K P Guan T 2015Drug Design Development & Therapy2015,,:1
11Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture显示文摘Maurizio Rossini Sblendorio Stefano Lello Davide Gatti Adami Elena Fracassi Viapiana 2013Drug Design Development and Therapy (default)2013,,:1
12Improved corneal bioavailability of ofloxacin:biodegradable microsphere-loaded ion-activated in situ gel delivery system显示文摘SAYED E G HUSSEIN A K KHALED K A 2015Drug Design Development and Therapy2015,9,9:1
13Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients显示文摘Sofue T Inui M Hara T 2014Drug design development and therapy2014,8,5:1
14Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan显示文摘Noriyuki Masuda 2009Drug Design Development and Therapy (default)2009,,:1
15Advances with RNA interference in Alzheimer’s disease research显示文摘Weien Yuan Yinghui Chen Xue-mei Ge Shun Chen Zhenguo Liu Nan Lu 2013Drug Design Development and Therapy (default)2013,,:1
16Comparison of reendothe- lializaiion and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine model 显示文摘Cui S Song XT Ding C 2015Drug Design Development and Therapy2015,33,35:1
17Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond显示文摘Sai-Hong Ignatius Ou 2011Drug Design Development and Therapy (default)2011,,:1
18Interferon-gamma and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment显示文摘Ren F Fan M Mei J 2014Drug Design Development and Therapy2014,8,:1
19Lack of the effect of lobeglitazone a peroxisome proliferator-activated receptor-γagonist on the pharmacokinetics and pharmacodynamics of warfarin显示文摘Ah Jung Jin Lee soo-Yun Kim Tae-eun 2015Drug Design Development and Therapy2015,9,:1
20Update on the development of lurasidone as a treatment for patients with acute schizophrenia显示文摘Norio Yasui-Furukori 2012Drug Design, Development and Therapy2012,,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费